:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/62695544/ER_project_year.0.jpg)

Sarah Kliff Read 1,182 Emergency Room Bills. Here’s What She LearnedDecember 19, 2018 |
A $5,571 bill to sit in a waiting room, $238 eyedrops, and a $60 ibuprofen tell the story of how emergency room visits are squeezing patients
Quick Read
Sarah Kliff Read 1,182 Emergency Room Bills. Here’s What She LearnedDecember 19, 2018 |
A $5,571 bill to sit in a waiting room, $238 eyedrops, and a $60 ibuprofen tell the story of how emergency room visits are squeezing patients
Quick Read
A Profusion of Diagnoses. That’s Good and BadNovember 6, 2018 |
With millions of Americans taking risky medications for questionable diagnoses, have we medicalized everyday life?
Quick Read
Why Doctors Hate Their ComputersNovember 5, 2018 |
Digitization promises to make medical care easier and more efficient. But are screens coming between doctors and patients? By Atul Gawande
Quick Read
1,495 Americans Describe the Financial Reality of Being Really SickOctober 17, 2018 |
The whole point of health insurance is protection from financial ruin in case of catastrophic, costly health problems. But a recent survey of people facing such problems shows that it often fails in that basic function
Quick Read
Dementia And Guns: When Should Doctors Broach The Topic?October 12, 2018 |
Some patients refuse to answer. Many doctors don’t ask. As the number of Americans with dementia rises, health professionals are grappling with when and how to pose the question: “Do you have guns at home?”
Quick Read
After Prison, Many People Living With HIV Go Without TreatmentOctober 11, 2018 |
When people living with HIV walk out of prison, they leave with up to a month’s worth of HIV medication in their pockets. What they don’t necessarily leave with is access to health care or the services that will keep them healthy in the long term
Quick Read
One of the World’s Largest Drug Makers is Paying Docs AgainOctober 10, 2018 |
And patients are the worse off. Ed Silverman writes, Seeking to recover from sensational marketing scandals, GlaxoSmithKline did something unexpected five years ago — the company promised it would no longer pay doctors to promote its medicines, which had been a long-standing industry practice
Quick Read